Karimah Es Sabar

Director, Capricor Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.8M

Companies

Latest trade

Apr 2, 2026

Companies

Capricor Therapeutics, Inc.Director −$3.8M

Trades

CAPR Sold 7,529 shares at $32.00 · planned $0.2M Apr 2

CAPR Sold 53,735 shares at $31.03 · planned $1.7M Apr 1

CAPR Sold 61,265 shares at $30.17 · planned $1.8M Mar 31

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.